Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients

Neuroendocrinology Letters

Volumn 32, Issue 1, 2011, Pages 39-43

  Arai, Motomi ^a  

^a SEIREI MIKATAHARA GENERAL HOSPITAL   (Japan)

Author keywords

Dopamine agonist; Hyponatremia; Levodopa; Parkinson's disease; Pergolide; Pramipexole; Side effects; Vasopressin

Indexed keywords

ARGIPRESSIN; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; PERGOLIDE; PRAMIPEXOLE; SELEGILINE;

ADULT; AGED; ARGIPRESSIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; GENDER; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; SIDE EFFECT;

EID: 79955042850     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Adhiyaman V, Hobson P, Meara RJ (2008). Central and peripheral autonomic integrity in Parkinson's disease. Age Ageing. 37:578-581.
2. Arai M, Iwabuchi M (2009). Pramipexole as a possible cause of the syndrome of inappropriate antidiuresis. BMJ Case Reports [doi: 10.1136/bcr.01.2009.1484]
3. Azdad K, Piet R, Poulain DA, Oliet SH (2003). Dopamine D4 receptor-mediated presynaptic inhibition of GABAergic transmission in the rat supraoptic nucleus. J Neurophysiol. 90:559-565.
4. Duggan J, Kilfeather S, Lightman SL, O'Malley K (1993). The association of age with plasma arginine vasopressin and plasma osmolality. Age Ageing. 22:332-336. (Pubitemid 23282358)
5. 2-adrenoceptors. J Pharmacol ExpTher. 298:1001-1006. (Pubitemid 32761915)
6. Forsling ML, Williams H (1984). Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat. J Physiol 346:49-59. (Pubitemid 14058463)
7. Jørgensen H, Kjær A, Knigge U, Møller M, Warberg J (2003). Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. J Neuroendocrinol. 15:564-571. (Pubitemid 36665407)
8. Li L, Schafer JA (1998). Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct. Am J Physiol. 275:F62-67.
9. Lightman SL, Forsling M (1980). Evidence for dopamine as an inhibitor of vasoprotein release in man. Clin Endocrinol. 12:39-46. (Pubitemid 10174980)
10. Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A (2002). Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther. 303:791-804.
11. Niimi Y, Ieda T, Hirayama M, Koike Y, Sobue G, Hasegawa Y, et al (1999). Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res. 9:139-144. (Pubitemid 29493493)
12. Purba JS, Hofman MA, Swaab DF (1994). Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson's disease. Neurology. 44:84-89. (Pubitemid 24029435)
13. Sundquist J, Forsling ML, Olsson JE, Åkerlund M (1983). Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases. J Neurol Neurosurg Psychiatry. 46:14-17. (Pubitemid 13159685)
14. Swenson KL, Badre SE, Morsette DJ, Sladek CD (1998). N-methyl-D-aspartic acid stimulation of vasopressin release: role in osmotic regulation and modulation by gonadal steroids. J Neuroendocrinol. 10:679-685. (Pubitemid 28393735)
15. 2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis. Endocrinology. 141:307-314. (Pubitemid 32260372)
16. Ueki A, Otsuka M (2004). Life style risks of Parkinson's disease: association between decreased water intake and constipation. J Neurol. 251(Suppl 7):18-23.
17. Willoughby JO, Jervois PM, Menadue MF, Blessing WW (1987). Noradrenaline, by activation of alpha-1-adrenoceptors in the region of the supraoptic nucleus, causes secretion of vasopressin in the unanaesthetized rat. Neuroendocrinology. 45:219-226. (Pubitemid 17023557)
18. 2 receptor activation depolarizes rat supraoptic neurones in hypothalamic expiants. J Physiol. 443:405-419.